Skip to main content
. 2010 Feb 26;285(17):12522–12535. doi: 10.1074/jbc.M109.059410

TABLE 2.

Intrinsic activities and potencies of opioids for receptor-G protein coupling

Data are derived from concentration response curve measured in membranes and are calculated and presented as in Table 1. enk, enkephalins; DAGO, [d-Ala2,N-Me-Phe4, glycinol5]-enkephalins.

Ligands DOPR/Gβ1
MOPR/Gβ1
Emax (±S.E.) Log EC50 (±S.E.) n Emax (±S.E.) Log EC50 (±S.E.) n
Bremazocine 0.51 (0.07) −7.9 (0.08) 3 0.22 (0.01) −9.4 (0.15) 5
Buprenorphine 0.14 (0.10) −8.8 (0.21) 3 0.65 (0.06) −8.8 (0.14) 4
DAGO 0.72a (0.04) −5.3a (0.13) 3 0.91 (0.07) −7.5 (0.07) 5
[d-Ala2]-deltorphin 1.03 (0.03) −7.7 (0.07) 3 1.02a (0.02) −5.3a (0.14) 4
Dermorphin 0.98a (0.06) −5.5a (0.34) 3 0.97 (0.06) −8.2 (0.15) 3
Diprenorphine 0.60 (0.07) −8.6 (0.08) 4 0.18 (0.04) −8.7 (0.26) 6
[d-Pen2,d-Pen5]-enk 1.01 (0.02) −7.5 (0.14) 3 0.98a (0.02) −5.7a (0.05) 3
Ethylketocyclazocine 0.75 (0.10) −7.5 (0.05) 3 0.65 (0.01) −8.5 (0.12) 3
Endomorphine 2 NM >−3 2 1.05 (0.04) −7.3 (0.11) 5
Etorphine 0.94 (0.07) −7.7 (0.10) 3 0.97 (0.01) −9.4 (0.10) 4
Fentanyl 0.99 (0.06) −5.5 (0.12) 3 0.98 (0.03) −8.0 (0.06) 3
Lofentanyl 0.99 (0.03) −8.3 (0.03) 4 1.11 (0.02) −9.5 (0.13) 4
Meperidine 1 −3.5 (0.1)(b) 2 0.86 (0.03) −5.6 (0.17) 3
Met-enkephalins 1.03 (0.12) −7.4 (0.10) 3 1.04 (0.08) −7.4 (0.12) 3
Morphiceptin 0.95a (0.05) −3.0a (0.36) 2 0.93 (0.042) −5.9 (0.02) 3
Morphine 0.75 (0.05) −5.7 (0.17) 3 0.73 (0.10) −7.8 (0.23) 3
Oxymorphone 0.87 (0.03) −5.7 (0.05) 3 0.94 (0.02) −8.1 (0.11) 4
SNC-121 1.10 (0.05) −6.9 (0.14) 3 NM >−3 2
UFP-512 0.60 (0.05) −8.9 (0.13) 4 0.59 (0.05) −7.4 (0.05) 5
[d-Ala2,d-leu5]-enk 1 −7.5 (0.04) 19 1 −7.3 (0.06) 24

a Values were extrapolated from data fitting but were not well defined experimentally because the curve did not reach a full upper asymptote.